Delaware
|
001-38238 |
06-1681204
|
(State or other jurisdiction of incorporation)
|
(Commission File Number)
|
(IRS Employer Identification Number)
|
☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Title of each class
|
Trading
Symbol(s)
|
Name of each exchange
on which registered
|
||
Common Stock, $0.0001 par value per share
|
VERO |
The Nasdaq Global Market
|
Item 5.07 |
Submission of Matters to a Vote of Security Holders.
|
Director
|
For
|
Withheld
|
Broker Non-Votes
|
Louise Lacchin
|
39,270,113
|
1,579,816
|
7,667,514
|
Anthony Natale, M.D.
|
39,257,176
|
1,592,753
|
7,667,514
|
S. Tyler Hollmig, M.D.
|
40,375,790
|
474,139
|
7,667,514
|
For
|
Against
|
Abstain
|
48,443,953
|
65,777
|
7,713
|
VENUS CONCEPT INC.
|
||
By:
|
/s/ Domenic Della Penna
|
|
Domenic Della Penna
|
||
Chief Financial Officer
|